I have an important question (fo me, anyway)

In last nights call it was stated that they now have proof that Leronlimab crosses the blood brain barrier, at least in certain cases. Does anyone know how they can see this? I assume Dr Patterson’s receptor occupancy test is used, but how do they see it? Does it light up under an MRI scan?

I ask because I’d like to have a talk with my wife’s oncologist, who despite being an attending physician at St Barnabas Medical Center (part of the CD 12 trial) never hear of Leronlimab. When I mentioned it to her previously, she didn’t think any mabs crossed the blood brain barrier.

I’d like to go into this conversation armed with as much information as I can.

I also want to thank so many on this forum for sharing their knowledge, wisdom, sense of humor, and investment acumen. I am a first time bio investor and have no knowledge of bio/chem science at all. Don’t even think I took chemistry in high school. I’ve learned a lot from listening and reading voraciously since I invested in Cytodyn, and this board has been a great resource. I also have to throw in, “There’s no place like Ohm!

Thanks everyone!